An innovative testing strategy helps more people living with HIV learn their status
“Life can deceive you when you think you feel strong and healthy,” says Godfrey Justin, whose wife, Violet, tested positive for HIV during a routine antenatal visit. After sharing her status with Godfrey, Violet asked that he be tested as well. Godfrey agreed, learned he was also living with HIV and the couple started antiretroviral therapy (ART).
On the eve of the 20th International AIDS Conference (AIDS 2014), Rachel Hassinger, editor of MSH’s Global Health Impact Blog, spoke with Dr. Scott Kellerman, global technical lead on HIV & AIDS, to discuss his latest research on prevention of mother-to-child transmission (PMTCT) of HIV and pediatric HIV & AIDS. Kellerman and colleagues will be attending AIDS 2014, July 20-25, in Melbourne, Australia. (Read more about the conference.)
Natalie Campbell and Elizabeth McLean of MSH and colleagues co-authored a new journal article, "Taking knowledge for health the extra mile: participatory evaluation of a mobile phone intervention for community health workers in Malawi," in the latest issue of Global Health: Science and Practice.
This post originally appeared on the K4Health blog.
The World Health Organization (WHO) made waves at the International AIDS Society conference in Kuala Lumpur when it issued revised guidelines for HIV treatment. The new guidelines—WHO’s first major update since 2010—recommend an earlier start to treatment, from a CD4 threshold of 350 cells/mm3 to 500 cells/mm3.
This week’s Lancet returns the spotlight to Option B+, an innovative strategy for preventing mother-to-child transmission of HIV which was first developed in Malawi with technical assistance from MSH. Four letters respond to the concern that international organizations have too quickly endorsed the Option B+ approach of providing lifelong triple antiretroviral therapy (ART), irrespective of CD4 count, to pregnant women with HIV in high-burden countries.
I got a call from the resident doctor to come to exam room 6. As soon as I entered the room, I prepared myself. The little girl, 7- or maybe 8-years-old, didn't look well; she was “floppy,” combative, and not entirely aware of where she was or what we were doing to her. She was HIV-positive, and my colleague needed to get an IV line in her arm to test the latest in experimental treatments for kids with HIV– and needed the four of us interns to help hold her still.It was 1993 during my residency in pediatrics in Cleveland, Ohio.
The Ugandan government launched a new prevention of mother-to-child HIV transmission (PMTCT) strategy on September 12.
Uganda will transition from an approach based on the World Health Organization's (WHO) Option A --- which is contingent on an HIV-positive pregnant woman’s CD4 count --- to WHO's newest PMTCT strategy, Option B+.